Additionally, these genes were enriched in 73 KEGG pathways (Supplementary Table S13), and the top 10 pathways were screened according to adjusted-P value <0.05, including prostate cancer, chemical carcinogenesis-receptor activation, the Foxo signaling pathway, Th17 cell differentiation, lipid and atherosclerosis, alcoholic liver disease, pancreatic cancer, the intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, and breast cancer pathways (Figure 5B). This evidence concerns the gene CD79A and breast carcinoma.